{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T18:40:59Z","timestamp":1747161659009,"version":"3.40.5"},"reference-count":79,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.gofs.2017.02.001","type":"journal-article","created":{"date-parts":[[2017,3,23]],"date-time":"2017-03-23T09:02:29Z","timestamp":1490259749000},"page":"224-230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pour une prescription cibl\u00e9e de l\u2019aspirine"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2742-9259","authenticated-orcid":false,"given":"H.","family":"Madar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Brun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Coatleven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Nithart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Lecoq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Gleyze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Merlot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Sentilhes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.gofs.2017.02.001_bib0005","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1517\/14656566.2015.1066335","article-title":"Aspirin and heparin in pregnancy","volume":"16","author":"Grandone","year":"2015","journal-title":"Expert Opin Pharmacother"},{"issue":"5","key":"10.1016\/j.gofs.2017.02.001_bib0010","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/bjh.12813","article-title":"Antithrombotic treatment for pregnancy complications: which path for the journey to precision medicine?","volume":"165","author":"Greer","year":"2014","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.gofs.2017.02.001_bib0015","first-page":"CD006780","article-title":"Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction","volume":"24","author":"Dodd","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"author":"Clinical NICE Guideline","key":"10.1016\/j.gofs.2017.02.001_bib0020"},{"issue":"10","key":"10.1016\/j.gofs.2017.02.001_bib0025","doi-asserted-by":"crossref","first-page":"695","DOI":"10.7326\/M13-2844","article-title":"Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the US Preventive Services Task Force","volume":"160","author":"Henderson","year":"2014","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.gofs.2017.02.001_bib0030","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/tera.1420370310","article-title":"Aspirin exposure during the first 20\u00a0weeks of gestation and IQ at four years of age","volume":"37","author":"Klebanoff","year":"1988","journal-title":"Teratology"},{"issue":"3","key":"10.1016\/j.gofs.2017.02.001_bib0035","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.ajog.2004.10.598","article-title":"Aspirin use during early pregnancy and the risk of congenital abnormalities: a population-based case-control study","volume":"192","author":"Norgard","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"7974","key":"10.1016\/j.gofs.2017.02.001_bib0040","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0140-6736(76)93025-7","article-title":"Aspirin and congenital malformations","volume":"1","author":"Slone","year":"1976","journal-title":"Lancet"},{"issue":"24","key":"10.1016\/j.gofs.2017.02.001_bib0045","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM198912143212404","article-title":"The relation of aspirin use during the first trimester of pregnancy to congenital cardiac defects","volume":"321","author":"Werler","year":"1989","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.gofs.2017.02.001_bib0050","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1067\/mob.2002.127376","article-title":"Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis","volume":"187","author":"Kozer","year":"2002","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.gofs.2017.02.001_bib0055","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/pd.4403","article-title":"Low-dose aspirin for prevention of adverse outcomes related to abnormal placentation","volume":"34","author":"Bujold","year":"2014","journal-title":"Prenatal diagnosis"},{"issue":"3","key":"10.1016\/j.gofs.2017.02.001_bib0060","doi-asserted-by":"crossref","first-page":"228e1","DOI":"10.1016\/j.ajog.2011.11.019","article-title":"Nonsteroidal antiinflammatory drug use among women and the risk of birth defects","volume":"206","author":"Hernandez","year":"2012","journal-title":"Am J Obstet Gynecol"},{"issue":"7411","key":"10.1016\/j.gofs.2017.02.001_bib0065","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/bmj.327.7411.368","article-title":"Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study","volume":"327","author":"Li","year":"2003","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.gofs.2017.02.001_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01630479","article-title":"New insights into the mode of action of anti-inflammatory drugs","volume":"44","author":"Vane","year":"1995","journal-title":"Inflamm Res"},{"issue":"5","key":"10.1016\/j.gofs.2017.02.001_bib0075","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","article-title":"Prostaglandins and inflammation","volume":"31","author":"Ricciotti","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.gofs.2017.02.001_bib0080","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1542\/peds.53.2.201","article-title":"Kinetics of salicylate elimination by newborn infants of mothers who ingested aspirin before delivery","volume":"53","author":"Levy","year":"1974","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.gofs.2017.02.001_bib0085","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/cpt1975182210","article-title":"Distribution of salicylate between neonatal and maternal serum at diffusion equilibrium","volume":"18","author":"Levy","year":"1975","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.gofs.2017.02.001_bib0090","first-page":"551","article-title":"Low-dose aspirin in pregnancy","volume":"74","author":"Sibai","year":"1989","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.gofs.2017.02.001_bib0095","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0002-9378(94)70056-7","article-title":"Cardiac function in fetuses and newborns exposed to low-dose aspirin during pregnancy","volume":"171","author":"Di Sessa","year":"1994","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.gofs.2017.02.001_bib0100","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1055\/s-2005-864116","article-title":"Prenatal constriction of the fetal ductus arteriosus related to maternal pain medication?","volume":"209","author":"Schiessl","year":"2005","journal-title":"Z Geburtshilfe Neonatol"},{"issue":"6","key":"10.1016\/j.gofs.2017.02.001_bib0105","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2350\/07-11-0368.1","article-title":"Antenatal closure of the ductus arteriosus and hydrops fetalis","volume":"14","author":"Wyatt-Ashmead","year":"2011","journal-title":"Pediatr Dev Pathol"},{"issue":"1","key":"10.1016\/j.gofs.2017.02.001_bib0110","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1542\/peds.111.1.e77","article-title":"Low-dose aspirin in pregnancy: maternal and neonatal aspirin concentrations and neonatal prostanoid formation","volume":"111","author":"Leonhardt","year":"2003","journal-title":"Pediatrics"},{"issue":"12","key":"10.1016\/j.gofs.2017.02.001_bib0115","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1001\/jama.1970.03170380023004","article-title":"Studies on the detection of adverse drug reactions in the newborn. II. The effects of prenatal aspirin on newborn hemostasis","volume":"213","author":"Bleyer","year":"1970","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.gofs.2017.02.001_bib0120","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0022-3476(71)80122-1","article-title":"The effects of antenatal drug administration on aggregation of platelets of newborn infants","volume":"79","author":"Corby","year":"1971","journal-title":"J Pediatr"},{"issue":"2","key":"10.1016\/j.gofs.2017.02.001_bib0125","first-page":"CD004659","article-title":"Antiplatelet agents for preventing pre-eclampsia and its complications","volume":"18","author":"Duley","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.gofs.2017.02.001_bib0130","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1471-0528.1995.tb10872.x","article-title":"Low dose aspirin in pregnancy and early childhood development: follow-up of the collaborative low dose aspirin study in pregnancy","volume":"102","author":"CLASP collaborative group","year":"1995","journal-title":"Br J Obstet Gynaecol"},{"issue":"1","key":"10.1016\/j.gofs.2017.02.001_bib0135","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1542\/peds.2009-0994","article-title":"Prenatal low-dose aspirin and neurobehavioral outcomes of children born very preterm","volume":"125","author":"Marret","year":"2010","journal-title":"Pediatrics"},{"issue":"21","key":"10.1016\/j.gofs.2017.02.001_bib0140","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1001\/jama.2012.5034","article-title":"Association of aspirin use with major bleeding in patients with and without diabetes","volume":"307","author":"De Berardis","year":"2012","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.gofs.2017.02.001_bib0145","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.annfar.2009.02.015","article-title":"Prise en charge multidisciplinaire de la pr\u00e9-\u00e9clampsie. Recommandations formalis\u00e9es d\u2019experts communes [Multidisciplinary management of severe pre-eclampsia (PE). Experts\u2019 guidelines 2008]","volume":"28","author":"Soci\u00e9t\u00e9 fran\u00e7aise d\u2019anesth\u00e9sie et de r\u00e9animation","year":"2009","journal-title":"Ann Fr Anesth Reanim"},{"issue":"9575","key":"10.1016\/j.gofs.2017.02.001_bib0150","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/S0140-6736(07)60712-0","article-title":"Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data","volume":"369","author":"Askie","year":"2007","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.gofs.2017.02.001_bib0155","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1182\/asheducation-2014.1.393","article-title":"Anticoagulation in pregnancy complications","volume":"2014","author":"Middeldorp","year":"2014","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"7491","key":"10.1016\/j.gofs.2017.02.001_bib0160","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/bmj.38380.674340.E0","article-title":"Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies","volume":"330","author":"Duckitt","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.gofs.2017.02.001_bib0165","doi-asserted-by":"crossref","first-page":"i1753","DOI":"10.1136\/bmj.i1753","article-title":"High risk of pre-eclampsia identification G. Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies","volume":"353","author":"Bartsch","year":"2016","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.gofs.2017.02.001_bib0170","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1111\/1471-0528.14267","article-title":"Does tranexamic acid prevent postpartum haemorrhage? A systematic review of randomised controlled trials","volume":"123","author":"Ker","year":"2016","journal-title":"BJOG"},{"issue":"7","key":"10.1016\/j.gofs.2017.02.001_bib0175","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/aogs.12864","article-title":"Tranexamic acid for preventing postpartum blood loss at cesarean delivery: is evidence sufficient?","volume":"95","author":"Sentilhes","year":"2016","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"8842","key":"10.1016\/j.gofs.2017.02.001_bib0180","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/0140-6736(93)93004-K","article-title":"Meta-analysis of the literature or of individual patient data: is there a difference?","volume":"341","author":"Stewart","year":"1993","journal-title":"Lancet"},{"author":"American College of Obstetricians and Gynecologists","key":"10.1016\/j.gofs.2017.02.001_bib0185"},{"issue":"7","key":"10.1016\/j.gofs.2017.02.001_bib0190","first-page":"575","article-title":"Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary","volume":"36","author":"Magee","year":"2014","journal-title":"JOGC"},{"issue":"5","key":"10.1016\/j.gofs.2017.02.001_bib0195","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1046\/j.1471-0528.2003.t01-1-02097.x","article-title":"Randomised comparison of uterine artery Doppler and aspirin (100mg) with placebo in nulliparous women: the Essai Regional Aspirine M\u00e8re-Enfant study (Part\u00a02)","volume":"110","author":"Subtil","year":"2003","journal-title":"BJOG"},{"issue":"5","key":"10.1016\/j.gofs.2017.02.001_bib0200","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1471-0528.2003.t01-1-02097.x","article-title":"Aspirin (100mg) used for prevention of pre-eclampsia in nulliparous women: the Essai Regional Aspirine M\u00e8re-Enfant study (Part\u00a01)","volume":"110","author":"Subtil","year":"2003","journal-title":"BJOG"},{"issue":"2","key":"10.1016\/j.gofs.2017.02.001_bib0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2016.09.076","article-title":"The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis","volume":"216","author":"Roberge","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.gofs.2017.02.001_bib0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2016.10.016","article-title":"Antiplatelet therapy before or after 16\u00a0weeks\u2019 gestation for preventing preeclampsia: an individual participant data meta-analysis","volume":"216","author":"Meher","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"1\u20132","key":"10.1016\/j.gofs.2017.02.001_bib0215","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3109\/07420528.2012.717455","article-title":"Chronotherapy with low-dose aspirin for prevention of complications in pregnancy","volume":"30","author":"Ayala","year":"2013","journal-title":"Chronobiol Int"},{"issue":"4","key":"10.1016\/j.gofs.2017.02.001_bib0220","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1471-0528.1997.tb11497.x","article-title":"A meta-analysis of low dose aspirin for the prevention of intrauterine growth retardation","volume":"104","author":"Leitich","year":"1997","journal-title":"Br J Obstet Gynaecol"},{"issue":"2\u00a0Pt 1","key":"10.1016\/j.gofs.2017.02.001_bib0225","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/AOG.0b013e3181e9322a","article-title":"Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis","volume":"116","author":"Bujold","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.gofs.2017.02.001_bib0230","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.jgyn.2013.09.022","article-title":"Prevention du RCIU vasculaire [Prevention of IUGR]","volume":"42","author":"Nizard","year":"2013","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"10.1016\/j.gofs.2017.02.001_bib0235","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejogrb.2015.06.021","article-title":"Fetal growth restriction and intra-uterine growth restriction: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians","volume":"193","author":"Vayssiere","year":"2015","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"10.1016\/j.gofs.2017.02.001_bib0240","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00006254-199702000-00023","article-title":"Effectiveness of interventions to prevent or treat impaired fetal growth","volume":"52","author":"Gulmezoglu","year":"1997","journal-title":"Obstet Gynecol Surv"},{"issue":"5","key":"10.1016\/j.gofs.2017.02.001_bib0245","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1097\/01.AOG.0000429658.85846.f9","article-title":"ACOG Practice bulletin No.\u00a0134. Fetal growth restriction","volume":"121","author":"American College of Obstetricians and Gynecologists","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.gofs.2017.02.001_bib0250","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1515\/JPM.2008.050","article-title":"Intrauterine restriction (IUGR)","volume":"36","author":"Mandruzzato","year":"2008","journal-title":"J Perinat Med"},{"year":"2013","series-title":"The investigation and management of the small-for-gestational-age fetus","author":"Royal College of Obstetricians and Gynaecologists (RCOG)","key":"10.1016\/j.gofs.2017.02.001_bib0255"},{"issue":"10","key":"10.1016\/j.gofs.2017.02.001_bib0260","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1093\/humrep\/15.10.2220","article-title":"Recurrent miscarriage \u2013 an aspirin a day?","volume":"15","author":"Rai","year":"2000","journal-title":"Hum Reprod"},{"issue":"3","key":"10.1016\/j.gofs.2017.02.001_bib0265","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/01.AOG.0000137350.89939.2a","article-title":"Poor obstetric outcome in subsequent pregnancies in women with prior fetal death","volume":"104","author":"Frias","year":"2004","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.gofs.2017.02.001_bib0270","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1097\/01.AOG.0000287616.71602.d0","article-title":"Prediction and prevention of recurrent stillbirth","volume":"110","author":"Reddy","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.gofs.2017.02.001_bib0275","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/AOG.0b013e31819e9ee2","article-title":"ACOG Practice Bulletin No.\u00a0102: management of stillbirth","volume":"113","author":"American College of Obstetricians and Gynecologists","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gofs.2017.02.001_bib0280","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejogrb.2016.02.015","article-title":"Pregnancy loss: French clinical practice guidelines","volume":"201","author":"Huchon","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"9937","key":"10.1016\/j.gofs.2017.02.001_bib0285","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(14)60157-4","article-title":"Preconception low-dose aspirin and pregnancy outcomes: results from the EAGeR randomised trial","volume":"384","author":"Schisterman","year":"2014","journal-title":"Lancet"},{"issue":"17","key":"10.1016\/j.gofs.2017.02.001_bib0290","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1056\/NEJMoa1000641","article-title":"Aspirin plus heparin or aspirin alone in women with recurrent miscarriage","volume":"362","author":"Kaandorp","year":"2010","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.gofs.2017.02.001_bib0295","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.jgyn.2014.09.014","article-title":"Fausses couches precoces \u00ab\u00a0\u00e0 repetition\u00a0\u00bb\u00a0: bilan et prise en charge [Early recurrent miscarriage: evaluation and management]","volume":"43","author":"Gallot","year":"2014","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"issue":"3","key":"10.1016\/j.gofs.2017.02.001_bib0300","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1053\/j.semperi.2014.03.002","article-title":"Prediction and prevention of ischemic placental disease","volume":"38","author":"Friedman","year":"2014","journal-title":"Semin Perinatol"},{"issue":"5","key":"10.1016\/j.gofs.2017.02.001_bib0305","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/uog.12421","article-title":"Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis","volume":"41","author":"Roberge","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"17","key":"10.1016\/j.gofs.2017.02.001_bib0310","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1056\/NEJM199310213291701","article-title":"Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units","volume":"329","author":"Sibai","year":"1993","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.gofs.2017.02.001_bib0315","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1600-0412.2010.01030.x","article-title":"Placental abruption: epidemiology, risk factors and consequences","volume":"90","author":"Tikkanen","year":"2011","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"8","key":"10.1016\/j.gofs.2017.02.001_bib0320","first-page":"CD004832","article-title":"Aspirin for in vitro fertilisation","volume":"10","author":"Siristatidis","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.gofs.2017.02.001_bib0325","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/humupd\/dmm005","article-title":"Low-dose aspirin for in vitro fertilization: a systematic review and meta-analysis","volume":"13","author":"Gelbaya","year":"2007","journal-title":"Hum Reprod Update"},{"issue":"1","key":"10.1016\/j.gofs.2017.02.001_bib0330","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.fertnstert.2007.06.033","article-title":"Evidence of absence or absence of evidence? A reanalysis of the effects of low-dose aspirin in in vitro fertilization","volume":"90","author":"Ruopp","year":"2008","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.gofs.2017.02.001_bib0335","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.fertnstert.2008.12.069","article-title":"Evidence of absence or absence of evidence? A reanalysis of the effects of low-dose aspirin in in vitro fertilization","volume":"91","author":"Gelbaya","year":"2009","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.gofs.2017.02.001_bib0340","first-page":"CD002859","article-title":"Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant","volume":"18","author":"Empson","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.gofs.2017.02.001_bib0345","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.autrev.2011.10.006","article-title":"Obstetric antiphospholipid syndrome","volume":"11","author":"Galarza-Maldonado","year":"2012","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.gofs.2017.02.001_bib0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13317-013-0056-5","article-title":"Treatment of the antiphospholipid syndrome","volume":"5","author":"Galli","year":"2014","journal-title":"Auto Immun Highlights"},{"issue":"3","key":"10.1016\/j.gofs.2017.02.001_bib0355","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.autrev.2013.10.014","article-title":"Efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies: an international and collaborative meta-analysis","volume":"13","author":"Arnaud","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.gofs.2017.02.001_bib0360","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/annrheumdis-2016-209770","article-title":"EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and\/or antiphospholipid syndrome","volume":"76","author":"Andreoli","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.gofs.2017.02.001_bib0365","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2141.2007.06902.x","article-title":"The GOAL study: a prospective examination of the impact of factor\u00a0V Leiden and ABO(H) blood groups on haemorrhagic and thrombotic pregnancy outcomes","volume":"140","author":"Clark","year":"2008","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.gofs.2017.02.001_bib0370","doi-asserted-by":"crossref","first-page":"151e1","DOI":"10.1016\/j.ajog.2008.09.023","article-title":"Inherited thrombophilia and preeclampsia within a multicenter cohort: the Montreal Preeclampsia Study","volume":"200","author":"Kahn","year":"2009","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.gofs.2017.02.001_bib0375","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/jth.12509","article-title":"Is thrombophilia associated with placenta-mediated pregnancy complications? A prospective cohort study","volume":"12","author":"Rodger","year":"2014","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.gofs.2017.02.001_bib0380","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/AOG.0b013e3181c88918","article-title":"Prothrombin gene G20210A mutation and obstetric complications","volume":"115","author":"Silver","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.gofs.2017.02.001_bib0385","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1097\/AOG.0b013e3181a6e96a","article-title":"Genetic thrombophilias and intrauterine growth restriction: a meta-analysis","volume":"113","author":"Facco","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.gofs.2017.02.001_bib0390","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/AOG.0b013e3181c879ca","article-title":"The truth about inherited thrombophilias and pregnancy","volume":"115","author":"Branch","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.gofs.2017.02.001_bib0395","first-page":"CD004734","article-title":"Aspirin and\/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia","volume":"04","author":"de Jong","year":"2014","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718917300375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718917300375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T05:38:11Z","timestamp":1719121091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468718917300375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":79,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S2468718917300375"],"URL":"https:\/\/doi.org\/10.1016\/j.gofs.2017.02.001","relation":{},"ISSN":["2468-7189"],"issn-type":[{"type":"print","value":"2468-7189"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pour une prescription cibl\u00e9e de l\u2019aspirine","name":"articletitle","label":"Article Title"},{"value":"Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gofs.2017.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}